In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
 Giuseppe M C Rosano
Speaker
Giuseppe M C Rosano
Giuseppe M C Rosano Giuseppe M C Rosano

St Georges Medical School, London (United Kingdom of Great Britain & Northern Ireland)

Specialities : Chronic Heart Failure , Chronic Heart Failure, Pharmacology and Pharmacotherapy

Giuseppe M.C. Rosano is Professor of Cardiology and Consultant Cardiologist at the St George’s Hospitals NHS Trust University of London and Scientific Director of the Nutramed program at the IRCCS San Raffaele, in Rome. He is board member and Treasurer of the Heart Failure Association (HFA), Chairman of the Education committee of the HFA and Chairman of the Study Group on Diabetes and Hypertension of the HFA. He currently serves as an expert in the area of Cardiovascular Medicine for the European Assessment Office of the Italian Drug Agency (AIFA), he is core member of the Cardiovascular Working Party of the European Medicines Agency.

50 presentations from this speaker

ESC Webinars Series - Diabetes. Focus 2: SGLT2 Inhibitors - New data and guidelines change practice.

Event : Webinar 2020

  • Session : ESC Webinars 2020
  • Speaker : O Mosenzon (Jerusalem,IL), M Petrie (Glasgow,GB), GMC Rosano (London,GB)

How to optimise RAASi therapy in patients with hyperkalaemia.

Event : Webinar 2020

  • Session : HFA Webinars 2020
  • Speaker : EA Jankowska (Wroclaw,PL), GMC Rosano (London,GB), G Savarese (Stockholm,SE)

SGLT2 inhibition: Making waves in the heart failure landscape.

Event : HFA Discoveries 2020

  • Session : SGLT2 inhibition: Making waves in the heart failure landscape
  • Speaker : CS Lam (Singapore,SG), J Butler (Atlanta,US), M Petrie (Glasgow,GB), GMC Rosano (London,GB)
  • Organised by CHANGE IME in partnership with Leicester Diabetes Centre

Valvular heart disease in setting of acute heart failure.

Event : HFA Discoveries 2020

  • Session : Valvular heart disease in setting of acute heart failure
  • Speaker : GMC Rosano (London,GB), O Chioncel (Bucuresti,RO), T Ben Gal (Ramat Hasharon,IL)

Valvular heart disease in setting of acute heart failure: gaps in knowledge.

Event : HFA Discoveries 2020

  • Session : Valvular heart disease in setting of acute heart failure
  • Speaker : GMC Rosano (London,GB)

Valvular heart disease in setting of acute heart failure: introduction.

Event : HFA Discoveries 2020

  • Session : Valvular heart disease in setting of acute heart failure
  • Speaker : GMC Rosano (London,GB)

Changing habits: alcohol and tobacco.

Event : Heart Failure 2019

  • Session : Lifestyle interventions in chronic heart failure
  • Speaker : GMC Rosano (London,GB)

Drugs targeting cardiac metabolism.

Event : Heart Failure 2019

  • Session : Emerging therapies in heart failure
  • Speaker : GMC Rosano (London,GB)
  • Joint Session with the working group on pharmacotherapy of the ESC

Hyperkalaemia and heart failure therapy: maximising RAASi.

Event : Webinar 2019

  • Session : HFA Webinars 2019
  • Speaker : M Lainscak (Murska Sobota,SI), GMC Rosano (London,GB), P Seferovic (Belgrade,RS)

Medical therapy.

Event : Heart Failure 2019

  • Session : Atrial fibrillation and heart failure
  • Speaker : GMC Rosano (London,GB)
  • Joint Session with the European Heart Rhythm Association (EHRA)

New insights into the epidemiology.

Event : Heart Failure 2019

  • Session : A crosstalk between diabetes and heart failure
  • Speaker : GMC Rosano (London,GB)

Therapy with Sacubitril-Valsartan should begin in hospital - Con

Event : Heart Failure 2019

  • Session : The Grand Debate 1: Advances in medical and interventional treatment of heart failure
  • Speaker : GMC Rosano (London,GB)

Therapy with Sacubitril-Valsartan should begin in hospital - Rebuttal

Event : Heart Failure 2019

  • Session : The Grand Debate 1: Advances in medical and interventional treatment of heart failure
  • Speaker : E Velazquez (New Haven,US), GMC Rosano (London,GB)

Treasurer's Report .

Event : Heart Failure 2019

  • Session : HFA General Assembly
  • Speaker : GMC Rosano (London,GB)

Treating diabetes saves the heart.

Event : Heart Failure 2019

  • Session : Diabetes and heart failure
  • Speaker : GMC Rosano (London,GB)

Up-to-date management of diabetic patients with heart failure.

Event : Webinar 2019

  • Session : HFA Webinars 2019
  • Speaker : A Coats (Warwickshire,GB), GMC Rosano (London,GB), P Seferovic (Belgrade,RS)

Advancing the angina treatment paradigm.

Event : ESC Congress 2018

  • Session : Treating angina: the way forward
  • Speaker : GMC Rosano (London,GB)
  • Sponsored by SERVIER

Designing device and diagnostic trials in heart failure

Event : Heart Failure 2018

  • Session : Devices in heart failure - Will the regulatory changes affect clinical practice?
  • Speaker : GMC Rosano (London,GB)

Finding the sweet spot for glycaemic control in heart failure

Event : Heart Failure 2018

  • Session : Diabetes and heart failure - A 21st century global challenge
  • Speaker : GMC Rosano (London,GB)

Risks of therapeutic interchange in HFrEF

Event : Heart Failure 2018

  • Session : Chronic Heart Failure – Treatment
  • Speaker : GMC Rosano (London,GB)

Team's presentation

Event : Heart Failure 2018

  • Session : HFA Championships
  • Speaker : GMC Rosano (London,GB)

Acute right heart failure - Management

Event : ESC Congress 2017

  • Session : Acute failure of the forgotten ventricle
  • Speaker : GMC Rosano (London,GB)

Chronic heart failure (HFpEF and HFrEF).

Event : Heart Failure 2017

  • Session : Heart Failure 2017 Highlights
  • Speaker : GMC Rosano (London,GB)

Diabetes.

Event : Heart Failure 2017

  • Session : Heart failure patients with comorbidities
  • Speaker : GMC Rosano (London,GB)

Discussion - Raising treatment standards for angina patients.

Event : ESC Congress 2017

  • Session : Raising treatment standards for angina patients
  • Speaker : P Camici (Milano,IT), V Fuster (New York,US), GMC Rosano (London,GB), P Vardas (Athens,GR)
  • Sponsored by SERVIER

Heart failure medication: considerations in diabetes

Event : ESC Congress 2017

  • Session : Drug treatment of acute heart failure
  • Speaker : GMC Rosano (London,GB)

Key insights for clinical practice.

Event : ESC Congress 2017

  • Session : Raising treatment standards for angina patients
  • Speaker : GMC Rosano (London,GB)
  • Sponsored by SERVIER

Panel Q&A - Discussion - Lighting the way: a new path to manage hyperkalaemia.

Event : ESC Congress 2017

  • Session : Lighting the way: a new path to manage hyperkalaemia (EBAC Accredited)
  • Speaker : L Lund (Stockholm,SE), GMC Rosano (London,GB), M Kosiborod (Kansas,US)
  • Sponsored by AstraZeneca

Sarcoidosis.

Event : Heart Failure 2017

  • Session : Cardiomyopathies: what the clinical cardiologist should know about…
  • Speaker : GMC Rosano (London,GB)

Shedding light on the risk of moderate hyperkalaemia.

Event : ESC Congress 2017

  • Session : Lighting the way: a new path to manage hyperkalaemia (EBAC Accredited)
  • Speaker : GMC Rosano (London,GB)
  • Sponsored by AstraZeneca

What do the Guidelines say?

Event : Heart Failure 2017

  • Session : Guidelines in Daily Practice III: pharmacological management based on LVEF
  • Speaker : GMC Rosano (London,GB)

ACE - inhibitors should be replaced by LCZ696 as first line therapy for heart failure - CON

Event : ESC Congress 2016

  • Session : Controversies in heart failure
  • Speaker : GMC Rosano (London,GB)

Critical issues in antithrombotic therapy - Take home message

Event : ESC Congress 2016

  • Session : Critical issues in antithrombotic therapy
  • Speaker : GMC Rosano (London,GB)

Diabetes mellitus, hiperlipidaemia, obesity.

Event : Heart Failure 2016

  • Session : The new ESC Guidelines: Focus on co-morbidities
  • Speaker : GMC Rosano (London,GB)

Effects of neuropeptide Y on coronary artery vasomotor tone

Event : Heart Failure 2016

  • Session : Co-morbidities
  • Speaker : GMC Rosano (London,GB)

Heart failure with reduced ejection fraction: pharmacological management.

Event : Heart Failure 2016

  • Session : The new ESC Guidelines: Focus on chronic heart failure
  • Speaker : GMC Rosano (London,GB)

Hyper-Kalaemia as cause for discontinuation of RAASi in patients with heart failure

Event : Heart Failure 2016

  • Session : Drug therapy, other
  • Speaker : GMC Rosano (London,GB)

Introduction.

Event : Heart Failure 2016

  • Session : Optimizing RAAS inhibition in heart failure: novel treatment considerations for the management of hyperkalemia
  • Speaker : GMC Rosano (London,GB)
  • Organised by the Physicians Academy for Cardiovascular Education (PACE) Foundation / Course Director: Prof Adriaan A Voors / Supported by an unrestricted educational grant from AstraZeneca

LCZ696 and drug-drug interactions?

Event : Heart Failure 2016

  • Session : What a busy clinician needs to know about LCZ696 for heart failure
  • Speaker : GMC Rosano (London,GB)

Management of chronic heart failure: pharmacology.

Event : Heart Failure 2016

  • Session : The new ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure - Overview
  • Speaker : GMC Rosano (London,GB)

Panel discussion.

Event : Heart Failure 2016

  • Session : Optimizing RAAS inhibition in heart failure: novel treatment considerations for the management of hyperkalemia
  • Speaker : F Zannad (Vandoeuvre,FR), GMC Rosano (London,GB)
  • Organised by the Physicians Academy for Cardiovascular Education (PACE) Foundation / Course Director: Prof Adriaan A Voors / Supported by an unrestricted educational grant from AstraZeneca

Welcome to Heart Failure 2016.

Event : Heart Failure 2016

  • Session : Inaugural Session
  • Speaker : GMC Rosano (London,GB)

A case of chronic heart failure with high heart rate - What do the Guidelines say?

Event : ESC Congress 2015

  • Session : Heart failure
  • Speaker : GMC Rosano (London,GB)

Are anti-cancer drugs approved more easily than cardiovascular drugs?

Event : ESC Congress 2015

  • Session : Cardiotoxicity of anti-cancer drugs
  • Speaker : GMC Rosano (London,GB)

Common clinical issues in cardiology - Take home message.

Event : ESC Congress 2015

  • Session : Common clinical issues in cardiology
  • Speaker : GMC Rosano (London,GB)

Discussion: TITRATION.

Event : Heart Failure 2015

  • Session : Late Breaking Trials I: Therapies for acute and advanced heart failure
  • Speaker : GMC Rosano (London,GB)

Managing obesity in heart failure: from behavioural therapy to surgery.

Event : ESC Congress 2015

  • Session : Nutritional deficiencies and excesses in heart failure
  • Speaker : GMC Rosano (London,GB)

Novel drugs on the horizon.

Event : Heart Failure 2015

  • Session : Metabolic targets in heart failure
  • Speaker : GMC Rosano (London,GB)

The regulatory perspective (EMA-FDA).

Event : ESC Congress 2014

  • Session : Cardiovascular safety of antidiabetic drugs
  • Speaker : GMC Rosano (London,GB)

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are